Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Coptidis Rhizoma for the Treatment of Alzheimer's Disease

Abstract

BackgroundAlzheimer's disease (AD) is becoming a more prevalent public health issue in today's culture. The experimental study of Coptidis Rhizoma (CR) and its chemical components in AD treatment has been widely reported, but the principle of multi-level and multi-mechanism treatment of AD urgently needs to be clarified.ObjectiveThis study focuses on network pharmacology to clarify the mechanism of CR's multi-target impact on Alzheimer's disease.MethodsThe Phytochemical-compounds of CR have been accessed from the Traditional Chinese Medicine Database and Analysis Platform (TCMSP) and Symmap database or HPLC determination. The values of Oral Bioavailability (OB) ≥ 30% and Drug Like (DL) ≥ 0.18 or blood ingredient were used to screen the active components of CR; the interactive network of targets and compounds were constructed by STRING and Cytoscape platform, and the network was analyzed by Molecular Complex Detection (MCODE); Gene Ontology (GO) function, Kyoto Encyclopedia of Genes and Genomes Pathway (KEGG) and metabolic pathway enrichment of targets were carried out with Metascape, the Database for Annotation, Visualization and Integrated Discovery (DAVID) and MetaboAnalyst platform; Based on CytoHubba, the potential efficient targets were screened by Maximal Clique Centrality (MCC) and Degree, the correlation between potential efficient targets and amyloid β-protein (Aβ), Tau pathology was analyzed by Alzdata database, and the genes related to aging were analyzed by Aging Altas database, and finally, the core targets were obtained; the binding ability between ingredients and core targets evaluated by molecular docking, and the clinical significance of core targets was assessed with Gene Expression Omnibus (GEO) database.Results19 active components correspond to 267 therapeutic targets for AD, of which 69 is potentially effective; in module analysis, RELA, TRAF2, STAT3, and so on are the critical targets of each module; among the six core targets, RELA, MAPK8, STAT3, and TGFB1 have clinical therapeutic significance; GO function, including 3050 biological processes (BP), 257 molecular functions (MF), 184 cellular components (CC), whose functions are mainly related to antioxidation, regulation of apoptosis and cell composition; the HIF-1 signaling pathway, glutathione metabolism is the most significant result of 134 KEGG signal pathways and four metabolic pathways, respectively; most of the active components have an excellent affinity in docking with critical targets.ConclusionThe pharmacological target prediction of CR based on molecular network pharmacology paves the way for a multi-level networking strategy. The study of CR in AD treatment shows a bright prospect for curing neurodegenerative diseases.

Exploring the mechanism of Alisma orientale for the treatment of pregnancy induced hypertension and potential hepato-nephrotoxicity by using network pharmacology, network toxicology, molecular docking and molecular dynamics simulation

“…STRING ( Szklarczyk et al, 2021 ) ( http://string-db.org , Version 11.5) database was used to construct a PPI network of the anti-PIH effect of AO, with species limited to “ Homo sapiens ” and interaction score >0.4. The Cytoscape plug-ins Cytohubba and MCODE (molecular complex detection) were used to analyze the topological parameters and select the core targets of AO anti-HIP with high accuracy and exhibit the complex relationship between disease and herb ( Ye et al, 2022 ). The same steps were used to construct the PPI network of network toxicology.…”

Network pharmacology analysis reveals neuroprotective effects of the Qin-Zhi-Zhu-Dan Formula in Alzheimer’s disease

“…The protein-protein interaction (PPI) network ( Wang et al, 2020 ) reflects behaviors and properties of biomolecules, which helps to understand the role of multiple proteins in complex diseases such as AD. The Search Tool for the Retrieval of Interaction Gene/Proteins (STRING) database 11 is commonly used to construct PPI network in network pharmacology studies ( Yao et al, 2022 ; Ye et al, 2022 ; Yu et al, 2022 ). The purpose of the STRING database is to collect, score and integrate all publicly available sources of protein-protein interaction information, and to supplement the information with computational predictions ( Szklarczyk et al, 2019 ).…”

“…Though a great deal of manpower, resources and money have been invested in studies on this disease over the past century, there is still no effective drug for its prevention and treatment ( Liang et al, 2022 ). As AD is a complex disease involving many factors, its etiology and pathogenesis are not clear, and single-target, single-acting drugs cannot delay the progression ( Ye et al, 2022 ). At present, there are many studies ( Yu et al, 2020 ; Wang X. et al, 2021 ) on the application of therapeutic methods of traditional Chinese medicine (TCM), such as Chinese herbal medicine and acupuncture, in the treatment of AD, which provides some enlightenment.…”

Exploring the common pathogenesis of Alzheimer’s disease and type 2 diabetes mellitus via microarray data analysis

“…Gene ontology (GO) is a multifaceted annotation of the genome for biological processes, cellular components, and molecular functions (Ye et al, 2022). The Kyoto Encyclopedia of Genome and Genome (KEGG) annotates the genetic pathways of different species in many ways, providing information about biological functions (Ye et al, 2020).…”